1. Home
  2. NAUT

NAUT

Nautilus Biotechnolgy Inc.

Logo Nautilus Biotechnolgy Inc.

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

as 04-12-2024 10:31am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

Founded: 2016 Country:
United States
United States
Employees: N/A City: SEATTLE
Market Cap: 337.8M IPO Year: N/A
Target Price: $6.00 AVG Volume (30 days): 78.6K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.51 EPS Growth: N/A
52 Week Low/High: $2.16 - $4.65 Next Earning Date: 04-30-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 8016.30%

Share on Social Networks: